Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative sleep quality and pain after breast cancer surgery
ChiCTR2200061818Phase 4Completed
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in breast cancer comparing Group E (Esketamine) with Group C (placebo) (2 arms). Primary endpoint: Richards Campbell Sleep Questionnaire (RCSQ). Started Jul 2022; status: completed.
02
Drugs
esketamine
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2200061818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061818.